Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

University of Oxford

23 clinical trials · 23 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by University of Oxford

RECRUITINGNCT04058457

DBS and Respiration

Patients referred to neurosurgery routinely and safely undergo deep brain stimulation (DBS) for treatment of neurological conditions, most commonly Parkinson's disease. The...

Sponsor: University of OxfordEnrolling: 601 location
Parkinson Disease
RECRUITINGNCT05878912

The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction

This study looks at the effects of weight loss in people who have heart failure with preserved ejection fraction (HFpEF) and are overweight or obese. The main questions it aims...

Sponsor: University of OxfordEnrolling: 1201 location
Heart Failure With Preserved Ejection FractionObesity
RECRUITINGEarly Phase 1NCT06628154

Losartan and Emotional Learning

This study explores the effects of single-dose losartan (50mg) versus placebo on emotional processing in healthy volunteers.

Sponsor: University of OxfordEnrolling: 601 location
Emotional Processing
RECRUITINGNCT07424781

Fluoxetine on Emotional Experience (FLEX) Study

The goal of this clinical medicine study is to investigate how does antidepressant fluoxetine modulate anger processing in healthy young people . The main questions it aims is to...

Sponsor: University of OxfordEnrolling: 801 location
Depression - Major Depressive DisorderIrritabilityDepression
RECRUITINGNCT06983301

Brief Cognitive Behaviour Therapy (CBT) for Adolescent OCD in Routine Clinical Practice

Obsessive-Compulsive Disorder (OCD) is a common and often disabling condition in young people, characterised by distressing, intrusive thoughts, images or urges, and repetitive...

Sponsor: University of OxfordEnrolling: 253 locations
Obsessive Compulsive Disorder (OCD)CBT
RECRUITINGNCT05858528

HIPPOCRATES Prospective Observational Study

HIPPOCRATES is an Innovative Medicines Initiative (IMI) funded EU Consortium established to address key unmet clinical needs in psoriatic disease. As part of the project, the...

Sponsor: University of OxfordEnrolling: 250001 location
Psoriatic ArthritisPsoriasis
RECRUITINGNCT05962190

Short-term Fat Overfeeding on the Effects of Liver Metabolism

Despite work showing the overconsumption of saturated fatty acids (SFA) to be metabolically deleterious, debate continues about whether there is a link between SFA and...

Sponsor: University of OxfordEnrolling: 261 location
Liver FatCardiac FunctionLipid Disorder+1
RECRUITINGPhase 3NCT04381936

Randomised Evaluation of COVID-19 Therapy

RECOVERY is a randomised trial of treatments to prevent death in patients hospitalised with pneumonia. The treatments being investigated are: COVID-19: Lopinavir-Ritonavir,...

Sponsor: University of OxfordEnrolling: 700007 locations
Severe Acute Respiratory Syndrome
RECRUITINGNCT06526689

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

To characterise the innate pulmonary immune response and respiratory microbiome after recent exposure to M.tb and to evaluate how differences determine the outcome of M.tb exposure

Sponsor: University of OxfordEnrolling: 503 locations
TuberculosisLatent Tuberculosis
RECRUITINGNCT06658782

Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of...

Aim: To use magnetic resonance imaging (MRI) scans without contrast to help improve diagnosis of liver cancer in people who are at increased risk of developing liver cancer....

Sponsor: University of OxfordEnrolling: 3002 locations
CirrhosisCirrhosis Due to Hepatitis BCirrhosis and Chronic Liver Disease+3
RECRUITINGPhase 2NCT07074665

Dose Finding Trial of R21/Matrix-M in School Children

This trial is a double-blind, randomised, trial recruiting participants from the R21 phase IIb trial (VAC 076) which took place between May 2019 and July 2023 in Nanoro, Burkina...

Sponsor: University of OxfordEnrolling: 401 location
Malaria (Plasmodium Falciparum)
RECRUITINGNCT04529434

Star Homes Project 2

Malaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these diseases and want to...

Sponsor: University of OxfordEnrolling: 27501 location
MalariaRespiratory Tract Infection AcuteDiarrhoea;Acute
RECRUITINGPhase 1 / Phase 2NCT05790889

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

This is a Phase IIb randomised controlled trial of the safety, immunogenicity and efficacy of the blood-stage malaria vaccine candidates RH5.1 in Matrix-MTM and RH5.2-VLP in...

Sponsor: University of OxfordEnrolling: 4801 location
Malaria,Falciparum
RECRUITINGPhase 4NCT04704999

Southeast Asia Dose Optimization of Tafenoquine

Tafenoquine was recently approved by regulatory authorities in the USA and Australia. Tafenoquine is an alternative radical curative treatment to primaquine acting against the...

Sponsor: University of OxfordEnrolling: 7005 locations
Plasmodium Vivax Malaria
RECRUITINGNCT05071079

A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes

The primary objectives of this study are to assess the safety and feasibility of blood-stage controlled human P. vivax malaria infection (CHMI) in healthy adult Thai volunteers...

Sponsor: University of OxfordEnrolling: 481 location
Plasmodium Vivax Infection
RECRUITINGNCT06821282

Surveillance of AMR in DRC

This study addresses knowledge gaps regarding antimicrobial resistance (AMR) in sub-Saharan Africa, focusing on evaluating the feasibility of AMR surveillance and enhancing local...

Sponsor: University of OxfordEnrolling: 2101 location
Bacteremia
RECRUITINGPhase 3NCT05951595

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and...

The goal of this open-label randomised, controlled, non-inferiority trial is to assess and compare the efficacy, tolerability and safety of a fixed dose TACT...

Sponsor: University of OxfordEnrolling: 16801 location
Uncomplicated Plasmodium Falciparum Malaria
RECRUITINGNCT07257965

Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

This study is a human challenge study to assess the minimum infective mosquito bite dose in a controlled human malaria Infection (via P. vivax sporozites) in healthy volunteers....

Sponsor: University of OxfordEnrolling: 241 location
Plasmodium Vivax Infection
RECRUITINGPhase 4NCT06068530

Mass Vaccine and Drug Administration, Bangladesh

This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug...

Sponsor: University of OxfordEnrolling: 100002 locations
Plasmodium Falciparum Malaria
RECRUITINGNCT04083508

Vivax Malaria Human Infection Studies in Thailand

This study is a human challenge study to assess the feasibility and safety of controlled human malaria infection (via P. vivax sporozites) in healthy volunteers, and to develop a...

Sponsor: University of OxfordEnrolling: 61 location
Plasmodium Vivax Infection
RECRUITINGPhase 1NCT06958198

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria...

This is a Phase Ib age de-escalation, dose escalation, open-label study to assess the safety and immunogenicity of the multi-stage malaria vaccine candidate R21 plus RH5.1 and/or...

Sponsor: University of OxfordEnrolling: 561 location
Malaria,Falciparum
RECRUITINGPhase 2NCT06488300

Assessing Antiviral Treatments in Early Symptomatic RSV

This trial will use a previously validated platform, to quantitatively assess antiviral effects in low-risk patients with high viral burdens and uncomplicated Respiratory...

Sponsor: University of OxfordEnrolling: 10002 locations
Respiratory Syncytial VirusRespiratory Syncytial Virus, Human
RECRUITINGPhase 2NCT05648448

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

This trial will use a previously validated platform, to quantitatively assess antiviral effects in low-risk patients with high viral burdens and uncomplicated influenza, to...

Sponsor: University of OxfordEnrolling: 30004 locations
InfluenzaInfluenza, Human